5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy
The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777 · cited 1×
“CpG islands are stretches of DNA approximately 1 kb long that are rich in CpG and GpC dinucleotides (Bird, 1986).”
BackgroundA gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,928
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831 · cited 1×
“DZCyd, which was synthesized as a more stable analog of ZCyd (Beisler, 1978) is at least an order of magnitude less potent than ZCyt in blocking in vivo methylation (Jones and Taylor, 1980; McGregor et al., 1989).”
BackgroundAberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
DNA methylation in health and disease
Robertson, K. D., & Wolffe, A. P. (2000) · Nature Reviews Genetics · doi:10.1038/35049533 · Cited by 1,057
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
Rountree, M. R., Bachman, K. E., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/77023 · Cited by 1,052
Cited by
Kulis, M., & Esteller, M. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60002-2 · Cited by 1,566
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
Cyclical DNA methylation of a transcriptionally active promoter
Métivier, R., Gallais, R., Tiffoche, C., Le Péron, C., Jurkowska, R. Z., Carmouche, R. P., Ibberson, D., Barath, P., Demay, F., Reid, G., et al. (2008) · Nature · doi:10.1038/nature06544 · Cited by 900
Issa, J.-P. J., Garcia-Manero, G., Giles, F. J., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C. S., Cortes, J., et al. (2004) · Blood · doi:10.1182/blood-2003-03-0687 · Cited by 809
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Welch, J. S., Petti, A. A., Miller, C. A., Fronick, C. C., O’Laughlin, M., Fulton, R. S., Wilson, R. K., Baty, J. D., Duncavage, E. J., Tandon, B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605949 · Cited by 796
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Targeting the epigenetic regulation of antitumour immunity
Hogg, S. J., Beavis, P. A., Dawson, M. A., & Johnstone, R. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0077-5 · Cited by 630
Brueckner, B., Garcia Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2957 · Cited by 545
DNMT1-interacting RNAs block gene-specific DNA methylation
Di Ruscio, A., Ebralidze, A. K., Benoukraf, T., Amabile, G., Goff, L. A., Terragni, J., Figueroa, M. E., De Figueiredo Pontes, L. L., Alberich-Jorda, M., Zhang, P., et al. (2013) · Nature · doi:10.1038/nature12598 · Cited by 509
Cashen, A. F., Schiller, G. J., O'Donnell, M. R., & DiPersio, J. F. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9178 · Cited by 464
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., & Jacob, S. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4727-4741.2005 · Cited by 431
RetractedCpG and non-CpG methylation in epigenetic gene regulation and brain function
Jang, H., Shin, W., Lee, J., & Do, J. (2017) · Genes · doi:10.3390/genes8060148 · Cited by 427
Fang, M. Z., Chen, D., Sun, Y., Jin, Z., Christman, J. K., & Yang, C. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0406 · Cited by 410
Self-citationE-cadherin: Its dysregulation in carcinogenesis and clinical implications
Wong, S. H. M., Fang, C. M., Chuah, L.-H., Leong, C. O., & Ngai, S. C. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.11.010 · Cited by 400
Palii, S. S., Van Emburgh, B. O., Sankpal, U. T., Brown, K. D., & Robertson, K. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01799-07 · Cited by 382
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V., & Verdin, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000495 · Cited by 374
Lee, W. J., & Zhu, B. T. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi206 · Cited by 372
Albrengues, J., Bertero, T., Grasset, E., Bonan, S., Maiel, M., Bourget, I., Philippe, C., Herraiz Serrano, C., Benamar, S., Croce, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms10204 · Cited by 367
Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer
Schuebel, K. E., Chen, W., Cope, L., Glöckner, S. C., Suzuki, H., Yi, J.-M., Chan, T. A., Neste, L. V., Criekinge, W. V., Bosch, S. V. D., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030157 · Cited by 347
Relevance of DNA methylation in the management of cancer
Esteller, M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01115-x · Cited by 329
Epigenetics—An Epicenter of Gene Regulation: Histones and Histone‐Modifying Enzymes
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461346 · Cited by 316
Retinoids in cancer therapy and chemoprevention: Promise meets resistance
Freemantle, S. J., Spinella, M. J., & Dmitrovsky, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206936 · Cited by 312
Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis
Dunn, J., Qiu, H., Kim, S., Jjingo, D., Hoffman, R., Kim, C. W., Jang, I., Son, D. J., Kim, D., Pan, C., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74792 · Cited by 307
Concise Drug Review: Azacitidine and Decitabine
Derissen, E. J. B., Beijnen, J. H., & Schellens, J. H. M. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0465 · Cited by 299
Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1
Lee, B. H., Yegnasubramanian, S., Lin, X., & Nelson, W. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505593200 · Cited by 295
Epigenetic Regulation of Pluripotency and Differentiation
Boland, M. J., Nazor, K. L., & Loring, J. F. (2014) · Circulation Research · doi:10.1161/circresaha.115.301517 · Cited by 271
Regulation of translocator protein 18kDa (TSPO) expression in health and disease states☆
Batarseh, A., & Papadopoulos, V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.013 · Cited by 270
Datta, J., Ghoshal, K., Denny, W. A., Gamage, S. A., Brooke, D. G., Phiasivongsa, P., Redkar, S., & Jacob, S. T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3669 · Cited by 270
RetractedDNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia
Yang, A. S., Doshi, K. D., Choi, S.-W., Mason, J. B., Mannari, R. K., Gharybian, V., Luna, R., Rashid, A., Shen, L., Estecio, M. R. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2385 · Cited by 266
The Role of DNA Methylation in Cancer
Lakshminarasimhan, R., & Liang, G. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-43624-1_7 · Cited by 259
Epigenetic regulation: A new frontier for biomedical engineers
Chen, Z., Li, S., Subramaniam, S., Shyy, J. Y.-J., & Chien, S. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044720 · Cited by 163
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
Sadida, H. Q., Abdulla, A., Marzooqi, S. A., Hashem, S., Macha, M. A., Akil, A. S. A.-S., & Bhat, A. A. (2024) · Translational Oncology · doi:10.1016/j.tranon.2023.101821 · Cited by 151
Sales, A. J., Biojone, C., Terceti, M. S., Guimarães, F. S., Gomes, M. V., & Joca, S. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01489.x · Cited by 147
Dnmt3a restrains mast cell inflammatory responses
Leoni, C., Montagner, S., Rinaldi, A., Bertoni, F., Polletti, S., Balestrieri, C., & Monticelli, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616420114 · Cited by 138
Current status and new treatment approaches in TP53 mutated AML
Hunter, A. M., & Sallman, D. A. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.05.004 · Cited by 102
The lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retina
Chen, D., Chao, D. L., Rocha, L., Kolar, M., Nguyen Huu, V. A., Krawczyk, M., Dasyani, M., Wang, T., Jafari, M., Jabari, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13100 · Cited by 109
Bam, M., Yang, X., Zhou, J., Ginsberg, J. P., Leyden, Q., Nagarkatti, P. S., & Nagarkatti, M. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9643-8 · Cited by 103
“5- AZA is believed to inhibit DNA methyltransferase at a lower concentration (Christman 2002).”
Fraga, H. P. F., Vieira, L. N., Caprestano, C. A., Steinmacher, D. A., Micke, G. A., Spudeit, D. A., Pescador, R., & Guerra, M. P. (2012) · Plant Cell Reports · doi:10.1007/s00299-012-1327-8 · Cited by 94
“The demethylation agents, 5-azacytidine (AzaC) and 5-aza-20-deoxycytidine, lead to a dose and time-dependent rapid fall in the DNA methyltransferase activity, causing hypomethylated DNA synthesis (Christman 2002).”
BackgroundDigging deep into “dirty” drugs – modulation of the methylation machinery
Pleyer, L., & Greil, R. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.995379 · Cited by 84
“Thus, aberrant DNA methylation patterns are no longer reproduced in the daughter cells, leading to DNA demethylation and subsequent gene (re-)activation (Christman, 2002; Stresemann & Lyko, 2008).”
BackgroundScheller, M., Ludwig, A. K., Göllner, S., Rohde, C., Krämer, S., Stäble, S., Janssen, M., Müller, J.-A., He, L., Bäumer, N., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00213-9 · Cited by 73
Fragile sites, chromosomal lesions, tandem repeats, and disease
Mirceta, M., Shum, N., Schmidt, M. H. M., & Pearson, C. E. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.985975 · Cited by 30
“These drugs cause widespread demethylation of DNA through both inhibition of DNMT1 and their incorporation into the genome (Christman, 2002).”
BackgroundThe Synergistic Effect of 5-Aza-2′-Deoxycytidine and 5-Fluorouracil on Drug-Resistant Tumors
Morita, S., Iida, S., Kato, K., Takagi, Y., Uetake, H., & Sugihara, K. (2006) · Oncology · doi:10.1159/000107110 · Cited by 29
The callus formation capacity of strawberry leaf explants is modulated by DNA methylation
Liu, D., Mu, Q., Li, X., Xu, S., Li, Y., & Gu, T. (2022) · Horticulture Research · doi:10.1093/hr/uhab073 · Cited by 29
Chanda, D., Hensel, J., Higgs, J., Grover, R., Kaza, N., & Ponnazhagan, S. (2017) · Genes · doi:10.3390/genes8090232 · Cited by 19
Activity-based CRISPR scanning uncovers allostery in DNA methylation maintenance machinery
(2023) · doi:10.7554/elife.80640 · Cited by 16
Allosteric activation of the SPRTN protease by ubiquitin maintains genome stability
Dürauer, S., Kang, H.-S., Wiebeler, C., Machida, Y., Schnapka, D. S., Yaneva, D., Renz, C., Götz, M. J., Weickert, P., Major, A. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61224-z · Cited by 6
UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN
(2025) · doi:10.1038/s41467-025-64977-9 · Cited by 1
Metadata
- Authors
- Christman, J. K.
- Venue
- Oncogene
- Published
- 2002-08-05
- Volume
- 21
- Issue
- 35
- Pages
- 5483-5495
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2086492419
- Cited by
- 1,525
- References
- 105
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.